科指受制4,300倒跌1.1% 在線醫療股全面反覆挫5%-9%
PCAOB上周聲明決定降低阿里巴巴(BABA.US)及京東(JD.US)等中企從美退市風險後,瑞信及花旗都認為投資者未來將聚焦於中概股基本面。此外,中央經濟工作會議結束,提出明年將恢復及擴大消費擺在優先位置,以及強調要支持平台企業在引領發展、創造就業、國際競爭中大顯身手。科指繼上周五隨美股續跌至4,048獲承接倒升後,今早高開0.5%報4,170獲承接,升幅擴至3.2%報4,283遇阻,掉頭向下,午後低見4,099,現報4,102,倒跌1.1%。
30隻科指成份股逾三分二受壓。雖然內地進一步優化疫情防控措施後,民眾搶購退燒感冒藥。然而,在線醫療股繼本月上旬創逾十個月至逾一年高遇阻後,近期股價顯著回吐,尤其是藍籌阿里健康(00241.HK)本月9日升至10.14元創逾一年高遇阻即市掉頭倒跌後,最近七個交易天僅上周五反彈,今天反覆挫8.9%報7.33元,為最傷科指成份股,股價失守20天線(7.42元),成交增至1.65億股。
平安好醫生(01833.HK)繼上周二升至34.2元創逾52周高遇阻即掉頭五連跌,今天高低見25.9/元23.2元,現報23.3元,反覆續跌7%,成交增至1,953萬股,股價失守20天線(23.9元)。
京東健康(06618.HK)繼本月9日升至90.75元創逾52周高遇阻後,股價反覆回落,今天高低見78.85元/72.15元,現報72.95元,反覆跌4.9%,股價失守20天線(73.6元)。
此外,非科指成份股的醫脈通(02192.HK)由逾十個月高位四連跌,今天高低見10.78元/9.47元,現報9.62元,反覆續挫9%,股價一舉失守100天及20天線(9.91元及10.16元)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.